Showing results (241-250 of 378) with videos related to
Sort By:
Pageof 38
Clinical Rheumatology|September 1, 1983
Plasma levels and response to prednisolone therapy in rheumatoid arthritisM De Silva, B L Hazleman, J Chakraborty, et al.General Pharmacology|January 1, 1987
Effects of cytotoxic drugs and inhibitors of insulin secretion on a serially transplantable rat insulinoma and cultured rat insulinoma cellsP R Flatt, S K Swanston-Flatt, K S Tan, et al.British Journal of Clinical Pharmacology|February 1, 1989
The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.British Journal of Clinical Pharmacology|August 1, 1975
Prednisolone levels in the plasma and urine: a study of two preparations in manJ English, J Chakraborty, V Marks, et al.Clinical Science (London, England : 1979)|April 1, 1988
Caffeine clearance and biotransformation in patients with chronic liver diseaseN R Scott, D Stambuk, J Chakraborty, et al.British Medical Journal|April 29, 1978
Prolongation and enhancement of serum methotrexate concentrations by probenecidG W Aherne, E Piall, V Marks, et al.The Journal of Endocrinology|June 1, 1984
Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) miceP R Flatt, C J Bailey, P Kwasowski, et al.Cancer|September 1, 1990
Breast sarcoma. A clinicopathologic review of 25 casesS G Pollard, P V Marks, L N Temple, et al.Clinical Chemistry|August 1, 1979
Improved double-antibody enzyme immunoassay for methotrexateM N Al-Bassam, M J O'Sullivan, J W Bridges, et al.Clinical Science (London, England : 1979)|December 24, 1997
Elevated post-prandial gastric inhibitory polypeptide concentrations in hypertriglyceridaemic subjectsR Gama, F Norris, L Morgan, et al.Pageof 38